Close

ANCA

Anti-neutrophil cytoplasmic antibodies (ANCA) are autoantibodies that cause systemic vascular inflammation by binding to target antigens of neutrophils. These autoantibodies can be found in serum from patients with systemic small-vessel vasculitis, and they are considered a biomarker for ANCA-associated vasculitis (AAV). There are two main kinds of ANCA. Each targets a specific protein inside white blood cells: cANCA, which targets a protein called PR3 (proteinase 3), and pANCA, which targets a protein called MPO (myeloperoxidase). An antigen-specific ANCA assay measures both cANCA (or PR3-ANCA) and pANCA (or MPO–ANCA) and is used to diagnose and monitor the treatment of the type of ANCA-associated small-vessel vasculitis such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) or polyarteritis nodosa (PAN).

Have questions about a product?

Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!

Contact A Specialist
Filter By:
Clear Results
2 Results
Name
Type
Format
Host/Source
Isotype
Tested Apps
Unit
Catalog
SDS
COA
Request Sample
Myeloperoxidase (panca)
Antigen, Other
Purified
Human Neutrophil
N/A
EIA
MG
A3C181H
Proteinase 3 antigen (canca)
Antigen, Other
Purified
Human Neutrophil
N/A
EIA
MG
A3C192H

Get In Touch With A Specialist

Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!

By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.

Learn More About Us

Learn More

Welcome to

Please select your country to continue

Continue
EN